Archer Investment Corporation’s GSK GSK Stock Holding History

Archer Investment Corporation’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11K	Hold	200	–	–	﹤0.01%	773
2025 Q4	$9.81K	Hold	200	–	–	﹤0.01%	728
2025 Q3	$8.63K	Hold	200	–	–	﹤0.01%	749
2025 Q2	$7.68K	Hold	200	–	–	﹤0.01%	755
2025 Q1	$7.75K	Hold	200	–	–	﹤0.01%	735
2024 Q4	$6.76K	Hold	200	–	–	﹤0.01%	768
2024 Q3	$8.18K	Hold	200	–	–	﹤0.01%	726
2024 Q2	$7.7K	Sell	200 -52	-21%	-$2.19K	﹤0.01%	706
2024 Q1	$10.8K	Buy	252 +1	+0.4%	+$41	﹤0.01%	641
2023 Q4	$9.32K	Hold	251	–	–	﹤0.01%	666
2023 Q3	$9.1K	Buy	251 +1	+0.4%	+$35	﹤0.01%	644
2023 Q2	$8.93K	Hold	250	–	–	﹤0.01%	637
2023 Q1	$8.89K	Buy	250 +50	+25%	+$1.75K	﹤0.01%	580
2022 Q4	$7.03K	Hold	200	–	–	﹤0.01%	583
2022 Q3	$5.89K	Buy	+200	New	+$7.58K	﹤0.01%	577
2021 Q1	–	Sell	-6,480	Closed	-$298K	–	758
2020 Q4	$298K	Hold	6,480	–	–	0.14%	158
2020 Q3	$305K	Hold	6,480	–	–	0.16%	141
2020 Q2	$330K	Hold	6,480	–	–	0.19%	128
2020 Q1	$307K	Hold	6,480	–	–	0.21%	115
2019 Q4	$381K	Buy	6,480 +480	+8%	+$26.7K	0.2%	121
2019 Q3	$320K	Buy	6,000 +800	+15%	+$41.2K	0.19%	136
2019 Q2	$260K	Hold	5,200	–	–	0.17%	151
2019 Q1	$272K	Hold	5,200	–	–	0.18%	149
2018 Q4	$248K	Buy	+5,200	New	+$256K	0.22%	140

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Archer Investment Corporation's GSK Position: Q1 2026 in Review

Archer Investment Corporation held its GSK (GSK) position steady in Q1 2026 at 200 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Archer Investment Corporation first reported a position in GSK in Q4 2018 and has held it in 24 quarters since. The position peaked at $381K in Q4 2019. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Archer Investment Corporation held 200 shares of GSK worth $11K as of Q1 2026.
Archer Investment Corporation left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #773 holding.
Archer Investment Corporation first reported a position in GSK in Q4 2018 and has held it in 24 quarters since.
Archer Investment Corporation's GSK position peaked at $381K in Q4 2019.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.